394 related articles for article (PubMed ID: 37724325)
1. Adiponectin: friend or foe in obesity and inflammation.
Luo L; Liu M
Med Rev (2021); 2022 Aug; 2(4):349-362. PubMed ID: 37724325
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin, obesity, and cardiovascular disease.
Fasshauer M; Paschke R; Stumvoll M
Biochimie; 2004 Nov; 86(11):779-84. PubMed ID: 15589686
[TBL] [Abstract][Full Text] [Related]
3. Signaling mechanisms underlying the insulin-sensitizing effects of adiponectin.
Cheng KK; Lam KS; Wang B; Xu A
Best Pract Res Clin Endocrinol Metab; 2014 Jan; 28(1):3-13. PubMed ID: 24417941
[TBL] [Abstract][Full Text] [Related]
4. Multifaceted Physiological Roles of Adiponectin in Inflammation and Diseases.
Choi HM; Doss HM; Kim KS
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059381
[TBL] [Abstract][Full Text] [Related]
5. Roles of oxidative stress, adiponectin, and nuclear hormone receptors in obesity-associated insulin resistance and cardiovascular risk.
Matsuda M; Shimomura I
Horm Mol Biol Clin Investig; 2014 Aug; 19(2):75-88. PubMed ID: 25390017
[TBL] [Abstract][Full Text] [Related]
6. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin: an update.
Guerre-Millo M
Diabetes Metab; 2008 Feb; 34(1):12-8. PubMed ID: 18069030
[TBL] [Abstract][Full Text] [Related]
9. Extracellular vesicles are carriers of adiponectin with insulin-sensitizing and anti-inflammatory properties.
Blandin A; Amosse J; Froger J; Hilairet G; Durcin M; Fizanne L; Ghesquière V; Prieur X; Chaigneau J; Vergori L; Dray C; Pradère JP; Blandin S; Dupont J; Ducluzeau PH; Dubois S; Boursier J; Cariou B; Le Lay S
Cell Rep; 2023 Aug; 42(8):112866. PubMed ID: 37605533
[TBL] [Abstract][Full Text] [Related]
10. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
11. Synthetic peptides designed to modulate adiponectin assembly improve obesity-related metabolic disorders.
Hampe L; Xu C; Harris PWR; Chen J; Liu M; Middleditch M; Radjainia M; Wang Y; Mitra AK
Br J Pharmacol; 2017 Dec; 174(23):4478-4492. PubMed ID: 28945274
[TBL] [Abstract][Full Text] [Related]
12. The role of adiponectin signaling in metabolic syndrome and cancer.
Scheid MP; Sweeney G
Rev Endocr Metab Disord; 2014 Jun; 15(2):157-67. PubMed ID: 24019064
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin Synthesis, Secretion and Extravasation from Circulation to Interstitial Space.
da Silva Rosa SC; Liu M; Sweeney G
Physiology (Bethesda); 2021 May; 36(3):134-149. PubMed ID: 33904786
[TBL] [Abstract][Full Text] [Related]
14. Modulation of adiponectin as a potential therapeutic strategy.
Lim S; Quon MJ; Koh KK
Atherosclerosis; 2014 Apr; 233(2):721-728. PubMed ID: 24603219
[TBL] [Abstract][Full Text] [Related]
15. Fat-specific DsbA-L overexpression promotes adiponectin multimerization and protects mice from diet-induced obesity and insulin resistance.
Liu M; Xiang R; Wilk SA; Zhang N; Sloane LB; Azarnoush K; Zhou L; Chen H; Xiang G; Walter CA; Austad SN; Musi N; DeFronzo RA; Asmis R; Scherer PE; Dong LQ; Liu F
Diabetes; 2012 Nov; 61(11):2776-86. PubMed ID: 22807031
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin--a key adipokine in the metabolic syndrome.
Whitehead JP; Richards AA; Hickman IJ; Macdonald GA; Prins JB
Diabetes Obes Metab; 2006 May; 8(3):264-80. PubMed ID: 16634986
[TBL] [Abstract][Full Text] [Related]
17. New insight into adiponectin role in obesity and obesity-related diseases.
Nigro E; Scudiero O; Monaco ML; Palmieri A; Mazzarella G; Costagliola C; Bianco A; Daniele A
Biomed Res Int; 2014; 2014():658913. PubMed ID: 25110685
[TBL] [Abstract][Full Text] [Related]
18. [Mutltifaceted biological roles of adiponectin].
Cuerq C; Morineau G; Dufour-Rainfray D; Vatier C; Fellahi S; Vigouroux C; Genoux A; Lacorte JM; Charchour R; Fève B; Capeau J; Collet C; Bastard JP;
Ann Biol Clin (Paris); 2020 Jun; 78(3):243-252. PubMed ID: 32540813
[TBL] [Abstract][Full Text] [Related]
19. Clinical review: adiponectin biology and its role in inflammation and critical illness.
Robinson K; Prins J; Venkatesh B
Crit Care; 2011 Apr; 15(2):221. PubMed ID: 21586104
[TBL] [Abstract][Full Text] [Related]
20. Relationship of adipokine to insulin sensitivity and glycemic regulation in obese women--the effect of body weight reduction by caloric restriction.
Golubović MV; Dimić D; Antić S; Radenković S; Djindjić B; Jovanović M
Vojnosanit Pregl; 2013 Mar; 70(3):284-91. PubMed ID: 23607240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
